Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
AstraZeneca
Medtronic
Johnson and Johnson

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Ecgonine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Ecgonine?

Ecgonine is an investigational drug.

There have been 5 clinical trials for Ecgonine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2013.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Renal Insufficiency, and Opioid-Related Disorders. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), Indivior Inc., and Johns Hopkins University.

There are three hundred and eighteen US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Ecgonine
TitleSponsorPhase
Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal FunctionCognitive Research CorporationPhase 1
Pharmacokinetic Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Subjects With Normal Renal FunctionPharmaceutical Project Solutions, Inc.Phase 1
A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine AbuseIndivior Inc.Phase 2

See all Ecgonine clinical trials

Clinical Trial Summary for Ecgonine

Top disease conditions for Ecgonine
Top clinical trial sponsors for Ecgonine

See all Ecgonine clinical trials

US Patents for Ecgonine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Ecgonine   Start Trial Pharmaceutical compositions and methods of using the same GENUS LIFESCIENCES INC. (Allentown, PA)   Start Trial
Ecgonine   Start Trial Pharmaceutical compositions resistant to abuse EGALET LTD. (London, GB)   Start Trial
Ecgonine   Start Trial Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation Allergan, Inc. (Irvine, CA)   Start Trial
Ecgonine   Start Trial Cross-linked hyaluronic acid grafted with dextran GALDERMA S.A. (Cham, CH)   Start Trial
Ecgonine   Start Trial Pharmaceutical compositions and methods of using the same GNEUS LIFESCINECES INC. (Allentown, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Ecgonine

Drugname Country Document Number Estimated Expiration Related US Patent
Ecgonine Australia 2010211376 2029-02-06   Start Trial
Ecgonine Australia 2013257533 2029-02-06   Start Trial
Ecgonine Canada 2751627 2029-02-06   Start Trial
Ecgonine Denmark 2393487 2029-02-06   Start Trial
Ecgonine European Patent Office 2393487 2029-02-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
Medtronic
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.